Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Ionis Pharmaceuticals Inc

IONS
Current price
51.46 USD +0.05 USD (+0.10%)
Last closed 51.63 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 7 407 459 328 USD
Yield for 12 month +32.02 %
Week
Month
Year
IONS
21.11.2021 - 28.11.2021

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an antisense injection for the treatment of polyneuropathy caused by hereditary transthyretin amyloidosis in adults; and WAYLIVRA, an antisense medicine for treatment for familial chylomicronemia syndrome (FCS) and familial partial lipodystrophy. It also develops medicines for various indications that are in phase 3 study, including Eplontersen as a monthly self-administered subcutaneous injection to treat all types of ATTR; Olezarsen for patients with FCS and severe hypertriglyceridemia (SHTG); Donidalorsen for patients with hereditary angioedema; ION363 for patients with amyotrophic lateral sclerosis; Tofersen to inhibit the production of superoxide dismutase 1; Pelacarsen for patients with established cardiovascular disease and elevated lipoprotein(a); and Bepirovirsen to inhibit the production of viral proteins associated with hepatitis B virus. In addition, the company develops Cimdelirsen to inhibit the production of growth hormone receptor; IONIS-FB-LRx to inhibit the production of complement factor B and the alternative complement pathway; and ION224 to reduce the production of diacylglycerol acyltransferase 2. It has a strategic collaboration with Biogen for the treatment of neurological disorders; and collaboration and license agreement with Metagenomi, Inc, AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis, Roche, Swedish Orphan Biovitrum AB, and PTC Therapeutics. Ionis Pharmaceuticals, Inc. was incorporated in 1989 and is based in Carlsbad, California. Address: 2855 Gazelle Court, Carlsbad, CA, United States, 92010

Analytics

WallStreet Target Price

53.29 USD

P/E ratio

Dividend Yield

3.07 %

Current Year

+587 000 000 USD

Last Year

+810 000 000 USD

Current Quarter

+144 000 000 USD

Last Quarter

+188 000 000 USD

Current Year

+573 000 000 USD

Last Year

+799 000 000 USD

Current Quarter

+142 000 000 USD

Last Quarter

+185 000 000 USD

Key Figures IONS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -540 307 008 USD
Operating Margin TTM -99.35 %
PE Ratio
Return On Assets TTM -12.92 %
PEG Ratio 25.7033
Return On Equity TTM -90.01 %
Wall Street Target Price 53.29 USD
Revenue TTM 615 030 976 USD
Book Value 2.2 USD
Revenue Per Share TTM 4.31 USD
Dividend Share
Quarterly Revenue Growth YOY -9.7 %
Dividend Yield 3.07 %
Gross Profit TTM -257 866 000 USD
Earnings Share -2.87 USD
Diluted Eps TTM -2.87 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY -43.7 %
Profit Margin -66.57 %

Dividend Analytics IONS

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History IONS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield 3.07 %
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation IONS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 90.9091
Enterprise Value Revenue 10.7752
Price Sales TTM 12.044
Enterprise Value EBITDA -22.3537
Price Book MRQ 23.4906

Financials IONS

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators IONS

For 52 weeks

32.69 USD 51.89 USD
50 Day MA 46.78 USD
Shares Short Prior Month 9 704 705
200 Day MA 40.76 USD
Short Ratio 8.57
Shares Short 9 740 886
Short Percent 8.04 %